Vanguard U.S. Multifactor ETFVFMF
Type
ETF
Peer group
US equity: mid companies
Net assets
$558.6M
Expense ratio
0.18%
1-year return
+32.6%
3 years, a year
+22.2%
5 years, a year
+14.6%
12-month yield
1.09%
Holdings
594
What it aims to do.
Vanguard U.S. Multifactor ETF (the Fund) seeks to provide long-term capital appreciation by investing in stocks with relatively strong recent performance, strong fundamentals, and low prices relative to fundamentals as determined by the advisor.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| NEM Newmont Corp | 1.15% |
| HCA HCA Healthcare Inc | 0.95% |
| MO Altria Group Inc | 0.95% |
| MCK McKesson Corp | 0.92% |
| BMY Bristol-Myers Squibb Co | 0.90% |
| ABBV AbbVie Inc | 0.89% |
| MRK Merck & Co Inc | 0.89% |
| GILD Gilead Sciences Inc | 0.88% |
| MU Micron Technology Inc | 0.88% |
| REGN Regeneron Pharmaceuticals Inc | 0.86% |
More on VFMF.
- VFMF overview
- VFMF holdings
- VFMF risk
- VFMF costs
- VFMF money in and out
- VFMF share classes
- Compare VFMF with other funds
Returns after fees, from the fund's SEC filings up to Aug 2026. Past returns are not a promise. Not financial advice.